Pain Treatment Biotech Egalet Files for a $69 Million IPO

Published: Oct 17, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Egalet, which is developing abuse-deterrent oral products for the treatment of pain, filed on Wednesday with the SEC to raise up to $69 million in an initial public offering. The Malvern, PA-based company, which was founded in 1995, plans to list on the NASDAQ under the symbol EGLT.

Help employers find you! Check out all the jobs and post your resume.

Back to news